查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1822441

2032 年学习障碍治疗市场预测：按治疗类型、适应症、年龄层、最终用户和地区进行的全球分析

Learning Disabilities Treatment Market Forecasts to 2032 - Global Analysis By Therapy Type, Indication, Age Group, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球学习障碍治疗市场预计在 2025 年达到 51 亿美元，到 2032 年将达到 97 亿美元，预测期内的复合年增长率为 9.5%。

学习障碍治疗是指一系列旨在帮助患有学习障碍（例如阅读障碍、计算障碍或註意力相关障碍）的个人的干预措施、疗法和教育策略。其目标是透过解决阅读、写作、数学和理解方面的具体挑战来增强认知、学业和社交功能。治疗方法可能包括个人化教育计划 (IEP)、专业辅导、行为疗法、辅助技术和技能培训。早期诊断和根据个人需求量身定制的干预措施对于改善学习成果、增强自信心以及促进长期学业和人格发展至关重要。

辅助科技的进步

技术支援的平台支援个人化介入、即时进度追踪和多感官互动。与语言治疗、认知训练和行为分析的整合正在提升治疗效果。学校和诊所正在部署主导工具，以针对阅读障碍、注意力不足过动症和其他疾病制定个人化干预措施。公共和私人部门对教育科技和神经发育解决方案的投资正在推动相关技术的采用。这些动态使辅助技术成为学习障碍治疗市场的关键驱动力，并推动整体市场成长。

获得熟练专业人员的机会有限

农村和服务欠缺地区在诊断、干预和后续护理方面存在显着差异。高负荷病例和有限的培训基础设施影响了品质和一致性。远端医疗和混合模式的扩张速度不足以满足日益增长的需求。医疗路径脱节和跨学科合作的缺乏降低了治疗效果。儘管人们的意识和技术准备程度不断提高，但这些因素仍在限制市场扩张。

盛行率和早期诊断不断提高

早期诊断有助于及时干预，提高学业成绩，并减轻长期负担。小儿科、教育工作者和看护者在识别症状和启动治疗方面发挥关键作用。学校计画以及与数位平台的整合使更多人群能够参与其中。公共卫生措施和政策支持正在加强早期疗育策略。这些发展为市场成长创造了有利条件，并加速了学习障碍治疗解决方案的普及。

政策实施不一致

教育要求和医疗保险覆盖范围的地区差异使采用变得复杂。缺乏标准化的通讯协定和结果追踪限制了扩充性。倡导工作往往分散，阻碍了立法进程和相关人员的合作。医疗保健提供者面临着应对监管模糊性和报销缺口的挑战。这些限制带来了系统性风险，并限制了市场的全面发展。

COVID-19的影响

新冠疫情扰乱了学习障碍治疗市场，导致供应链暂时中断、服务交付出现缺口以及面对面评估延迟。教育机构、治疗中心和诊断机构的容量减少影响了医疗服务的连续性。然而，对心理健康、远距学习和数位疗法的关注度增加部分抵消了疫情后市场復苏的影响。对便利性、技术赋能和个人化学习支援解决方案的需求不断增长，以及不同使用者群体在居家介入和虚拟治疗平台方面的创新，共同推动着疫情后的復苏。

预计兴奋剂市场在预测期内将占据最大份额

兴奋剂领域预计将在预测期内占据最大的市场份额，这得益于其在治疗注意力相关症状（尤其是过动症）方面的广泛应用。药物介入措施通常与行为疗法同时使用，以改善注意力、控制衝动和提高学业成绩。监管部门的核准和临床指南正在加强兴奋剂在儿童和青少年群体中的应用。学校计画、门诊和居家医疗机构对兴奋剂的需求依然强劲。与数位监测和剂量优化工具的整合正在改善治疗效果，推动整体市场成长。

预测期内，家庭护理机构预计将以最高复合年增长率成长

预计在预测期内，家庭护理领域将实现最高成长率，这得益于对灵活、以家庭为中心且经济高效的治疗方案的需求。家长和看护者正在采用数位平台、治疗套件和远距会诊来支持家庭学习介入。远端医疗、进度追踪和游戏化学习模组的整合正在提高参与度和依从性。公共和私人措施正在扩大服务欠缺地区的居家照护覆盖范围。该领域已成为学习障碍治疗领域的高成长前沿，加速了市场扩张。

比最大的地区

由于儿科人口庞大、认知度不断提升以及教育基础设施不断扩展，预计亚太地区将在预测期内占据最大市场份额。中国、印度、日本和韩国等国家正在投资融合教育、早期筛检和数位学习平台。神经发育护理和学校介入方面的公共倡议正在增强需求。该地区的教育科技公司和医疗保健提供者正在扩大其在都市区和半都市区的业务。具竞争力的定价和政策协调正在推动相关技术的采用。

复合年增长率最高的地区

在预测期内，北美预计将实现最高的复合年增长率，这得益于其在心理健康、数位疗法和个人化教育领域的强劲投资。美国和加拿大正在扩大保险报销范围、远端医疗服务覆盖范围以及学校援助计画。官民合作关係和倡导活动正在推动创新和政策改革。对循证、技术驱动和以家庭为中心的护理的需求正在推动市场发展。新兴企业和学术机构在人工智慧、行为分析和治疗内容开发方面处于领先地位。

提供免费客製化

此报告的订阅者可以选择以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球学习障碍治疗市场（依治疗类型）

  • 兴奋剂
  • 无刺激性药物
  • 行为疗法
  • 教育疗法
  • 辅助技术
  • 其他的

6. 全球学习障碍治疗市场（按适应症）

  • 阅读障碍
  • 注意力不足过动症（ADHD）
  • 发展性协调障碍
  • 计算障碍
  • 语言处理障碍
  • 泛自闭症障碍（ASD）
  • 其他的

7. 全球学习障碍治疗市场（依年龄层）

  • 孩子们
  • 青年
  • 成人

8. 全球学习障碍治疗市场（依最终使用者）

  • 医院
  • 专科诊所
  • 教育机构
  • 居家照护环境
  • 復健中心
  • 研发中心
  • 其他的

9. 全球学习障碍治疗市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十章：重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司概况

  • Novartis AG
  • Pfizer Inc.
  • Eli Lilly and Company
  • Takeda Pharmaceutical Company Limited
  • Forest Laboratories
  • Sanofi SA
  • CogniFit Inc.
  • Therapro, Inc.
  • Tumble N'Dots
  • Texthelp Ltd.
  • Pearson Education Ltd.
  • Akili, Inc.
  • UCB SA
  • Lundbeck A/S
  • Jazz Pharmaceuticals plc
Product Code: SMRC31196

According to Stratistics MRC, the Global Learning Disabilities Treatment Market is accounted for $5.1 billion in 2025 and is expected to reach $9.7 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Learning Disabilities Treatment refers to a range of interventions, therapies, and educational strategies designed to support individuals with learning disorders, such as dyslexia, dyscalculia, or attention-related difficulties. The goal is to enhance cognitive, academic, and social functioning by addressing specific challenges in reading, writing, mathematics, and comprehension. Treatment approaches may include individualized education plans (IEPs), specialized tutoring, behavioral therapy, assistive technology, and skill-building exercises. Early diagnosis and tailored interventions are crucial to improving learning outcomes, fostering self-confidence, and promoting long-term academic and personal development for affected individuals.

Market Dynamics:

Driver:

Advancements in assistive technologies

Technology-enabled platforms are supporting personalized interventions, real-time progress tracking, and multisensory engagement. Integration with speech therapy, cognitive training, and behavioral analytics is enhancing treatment efficacy. Schools and clinics are adopting AI-driven tools to tailor support for dyslexia, ADHD, and other conditions. Public and private investments in edtech and neurodevelopmental solutions are reinforcing adoption. These dynamics are positioning assistive technologies as a key driver of the learning disabilities treatment market, thereby boosting overall market growth.

Restraint:

Limited access to skilled professionals

Rural and underserved areas face significant gaps in diagnosis, intervention, and follow-up care. High caseloads and limited training infrastructure are affecting quality and consistency. Telehealth and hybrid models are not scaling fast enough to meet growing demand. Fragmented care pathways and lack of interdisciplinary coordination are reducing treatment impact. These factors are tempering market expansion despite rising awareness and technological readiness.

Opportunity:

Increased prevalence and early diagnosis

Early diagnosis is enabling timely intervention, better academic outcomes, and reduced long-term burden. Pediatricians, educators, and caregivers are playing a critical role in identifying symptoms and initiating treatment. Integration with school-based programs and digital platforms is enhancing reach and engagement. Public health initiatives and policy support are reinforcing early intervention strategies. These developments are creating favorable conditions for market growth, thereby accelerating adoption of learning disabilities treatment solutions.

Threat:

Inconsistent implementation of policies

Regional disparities in education mandates and healthcare coverage are complicating deployment. Lack of standardized protocols and outcome tracking is limiting scalability. Advocacy efforts are often fragmented, slowing legislative progress and stakeholder alignment. Providers face challenges in navigating regulatory ambiguity and reimbursement gaps. These limitations are introducing systemic risk and constraining full-scale market development.

Covid-19 Impact:

The Covid-19 pandemic disrupted the Learning Disabilities Treatment market, causing temporary supply chain interruptions, service delivery gaps, and delays in in-person assessments. Educational institutions, therapy centers, and diagnostic facilities experienced reduced capacity, impacting treatment continuity. However, the increased focus on mental health, remote learning, and digital therapeutics partially offset the slowdown. Post-pandemic recovery is driven by growing demand for accessible, tech-enabled, and personalized learning support solutions, along with innovations in home-based interventions and virtual therapy platforms across user segments.

The stimulant medications segment is expected to be the largest during the forecast period

The stimulant medications segment is expected to account for the largest market share during the forecast period owing to its widespread use in managing attention-related symptoms, particularly in ADHD. Pharmacological interventions are being prescribed alongside behavioral therapies to improve focus, impulse control, and academic performance. Regulatory approvals and clinical guidelines are reinforcing adoption across pediatric and adolescent populations. Demand remains strong across school-based programs, outpatient clinics, and homecare settings. Integration with digital monitoring and dosage optimization tools is enhancing treatment outcomes, thereby boosting overall market growth.

The homecare settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare settings segment is predicted to witness the highest growth rate driven by demand for flexible, family-centered, and cost-effective treatment options. Parents and caregivers are adopting digital platforms, therapeutic kits, and remote consultations to support learning interventions at home. Integration with teletherapy, progress tracking, and gamified learning modules is enhancing engagement and adherence. Public and private initiatives are expanding access to home-based care in underserved regions. This segment is emerging as a high-growth frontier for learning disabilities treatment, thereby accelerating market expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to its large paediatric population, rising awareness, and expanding education infrastructure. Countries like China, India, Japan, and South Korea are investing in inclusive education, early screening, and digital learning platforms. Public initiatives in neurodevelopmental care and school-based interventions are reinforcing demand. Regional edtech firms and healthcare providers are scaling deployment across urban and semi-urban areas. Competitive pricing and policy alignment are supporting widespread adoption.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by strong investment in mental health, digital therapeutics, and personalized education. The U.S. and Canada are expanding reimbursement coverage, telehealth access, and school-based support programs. Public-private partnerships and advocacy efforts are accelerating innovation and policy reform. Demand for evidence-based, tech-enabled, and family-centered care is reinforcing market momentum. Startups and academic institutions are leading in AI, behavioural analytics, and therapeutic content development.

Key players in the market

Some of the key players in Learning Disabilities Treatment Market include Novartis AG, Pfizer Inc., Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Forest Laboratories, Sanofi S.A., CogniFit Inc., Therapro, Inc., Tumble N' Dots, Texthelp Ltd., Pearson Education Ltd., Akili, Inc., UCB S.A., Lundbeck A/S and Jazz Pharmaceuticals plc.

Key Developments:

In September 2025, Novartis entered into a licensing agreement with Monte Rosa Therapeutics, valued at up to $5.7 billion, to develop drugs for immune-mediated diseases. Novartis secured rights to develop and commercialize potential cardiovascular drugs from Shanghai-based Argo Biopharma in a deal worth up to $5.2 billion. These collaborations underscore Novartis's focus on expanding its portfolio in immunology and cardiovascular treatments.

In July 2025, Lilly expanded its clinical trial footprint across India, Brazil, and Southeast Asia, integrating decentralized models and digital endpoints for learning disability treatments. This expansion supports global access and accelerates data collection in diverse populations.

In April 2024, Takeda, along with Astellas Pharma and Sumitomo Mitsui Banking, established a joint venture company focused on advancing innovative drug discovery programs originating in Japan. The venture aims to incubate globally competitive drug discovery technology and foster entrepreneurship, potentially impacting treatments for neurodevelopmental disorders.

Therapy Types Covered:

  • Stimulant Medications
  • Non-Stimulant Medications
  • Behavioural Therapy
  • Educational Therapy
  • Assistive Technologies
  • Other Therapy Types

Indications Covered:

  • Dyslexia
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Dyspraxia
  • Dyscalculia
  • Language Processing Disorder
  • Autism Spectrum Disorder (ASD)
  • Other Indications

Age Groups Covered:

  • Children
  • Adolescents
  • Adults

End Users Covered:

  • Hospitals
  • Specialty Clinics
  • Educational Institutions
  • Homecare Settings
  • Rehabilitation Centers
  • Research & Development Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Learning Disabilities Treatment Market, By Therapy Type

  • 5.1 Introduction
  • 5.2 Stimulant Medications
  • 5.3 Non-Stimulant Medications
  • 5.4 Behavioral Therapy
  • 5.5 Educational Therapy
  • 5.6 Assistive Technologies
  • 5.7 Other Therapy Types

6 Global Learning Disabilities Treatment Market, By Indication

  • 6.1 Introduction
  • 6.2 Dyslexia
  • 6.3 Attention Deficit Hyperactivity Disorder (ADHD)
  • 6.4 Dyspraxia
  • 6.5 Dyscalculia
  • 6.6 Language Processing Disorder
  • 6.7 Autism Spectrum Disorder (ASD)
  • 6.8 Other Indications

7 Global Learning Disabilities Treatment Market, By Age Group

  • 7.1 Introduction
  • 7.2 Children
  • 7.3 Adolescents
  • 7.4 Adults

8 Global Learning Disabilities Treatment Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Specialty Clinics
  • 8.4 Educational Institutions
  • 8.5 Homecare Settings
  • 8.6 Rehabilitation Centers
  • 8.7 Research & Development Centers
  • 8.8 Other End Users

9 Global Learning Disabilities Treatment Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Novartis AG
  • 11.2 Pfizer Inc.
  • 11.3 Eli Lilly and Company
  • 11.4 Takeda Pharmaceutical Company Limited
  • 11.5 Forest Laboratories
  • 11.6 Sanofi S.A.
  • 11.7 CogniFit Inc.
  • 11.8 Therapro, Inc.
  • 11.9 Tumble N' Dots
  • 11.10 Texthelp Ltd.
  • 11.11 Pearson Education Ltd.
  • 11.12 Akili, Inc.
  • 11.13 UCB S.A.
  • 11.14 Lundbeck A/S
  • 11.15 Jazz Pharmaceuticals plc

List of Tables

  • Table 1 Global Learning Disabilities Treatment Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Learning Disabilities Treatment Market Outlook, By Therapy Type (2024-2032) ($MN)
  • Table 3 Global Learning Disabilities Treatment Market Outlook, By Stimulant Medications (2024-2032) ($MN)
  • Table 4 Global Learning Disabilities Treatment Market Outlook, By Non-Stimulant Medications (2024-2032) ($MN)
  • Table 5 Global Learning Disabilities Treatment Market Outlook, By Behavioral Therapy (2024-2032) ($MN)
  • Table 6 Global Learning Disabilities Treatment Market Outlook, By Educational Therapy (2024-2032) ($MN)
  • Table 7 Global Learning Disabilities Treatment Market Outlook, By Assistive Technologies (2024-2032) ($MN)
  • Table 8 Global Learning Disabilities Treatment Market Outlook, By Other Therapy Types (2024-2032) ($MN)
  • Table 9 Global Learning Disabilities Treatment Market Outlook, By Indication (2024-2032) ($MN)
  • Table 10 Global Learning Disabilities Treatment Market Outlook, By Dyslexia (2024-2032) ($MN)
  • Table 11 Global Learning Disabilities Treatment Market Outlook, By Attention Deficit Hyperactivity Disorder (ADHD) (2024-2032) ($MN)
  • Table 12 Global Learning Disabilities Treatment Market Outlook, By Dyspraxia (2024-2032) ($MN)
  • Table 13 Global Learning Disabilities Treatment Market Outlook, By Dyscalculia (2024-2032) ($MN)
  • Table 14 Global Learning Disabilities Treatment Market Outlook, By Language Processing Disorder (2024-2032) ($MN)
  • Table 15 Global Learning Disabilities Treatment Market Outlook, By Autism Spectrum Disorder (ASD) (2024-2032) ($MN)
  • Table 16 Global Learning Disabilities Treatment Market Outlook, By Other Indications (2024-2032) ($MN)
  • Table 17 Global Learning Disabilities Treatment Market Outlook, By Age Group (2024-2032) ($MN)
  • Table 18 Global Learning Disabilities Treatment Market Outlook, By Children (2024-2032) ($MN)
  • Table 19 Global Learning Disabilities Treatment Market Outlook, By Adolescents (2024-2032) ($MN)
  • Table 20 Global Learning Disabilities Treatment Market Outlook, By Adults (2024-2032) ($MN)
  • Table 21 Global Learning Disabilities Treatment Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Learning Disabilities Treatment Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Learning Disabilities Treatment Market Outlook, By Specialty Clinics (2024-2032) ($MN)
  • Table 24 Global Learning Disabilities Treatment Market Outlook, By Educational Institutions (2024-2032) ($MN)
  • Table 25 Global Learning Disabilities Treatment Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 26 Global Learning Disabilities Treatment Market Outlook, By Rehabilitation Centers (2024-2032) ($MN)
  • Table 27 Global Learning Disabilities Treatment Market Outlook, By Research & Development Centers (2024-2032) ($MN)
  • Table 28 Global Learning Disabilities Treatment Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.